Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

Company price
1.3512 USD 0.00(0%)
Last update at 2026-11-13T14:30:00Z
Market Cap
13.27M

Momentum Score

…

Healthy Extracts Inc., through its subsidiaries, engages in acquiring, developing, patenting, marketing, and distributing plant-based nutraceuticals in the United States. It operates through Corporate and Health Supplements segments. The company's proprietary and patented products target categories within the nutraceuticals market, such as heart, brain, and immune health. It also provides heart and immune health products, including bergamot-based products in tablet and capsule form; and plant-based health technology neuro-products that enhance brain health comprising memory, cognition, focus, and neuro-energy. The company was formerly known as Grey Cloak Tech Inc. and changed its name to Healthy Extracts Inc. in October 2020. Healthy Extracts Inc. was incorporated in 2014 and is headquartered in Henderson, Nevada.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
1.35
Low
1.35
High
52 Week Price Range
0.81
Low
2.70
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Public information on Grey Cloak Tech Inc (HYEX.US) is limited; the company is an OTCQB-listed issuer and detailed descriptions of its core business, products and markets are not available in public filings or company disclosures. Due to constrained disclosure, long-term growth drivers are unclear and investors may benefit only if management later demonstrates a clear strategy and tangible execution such as product development, revenue traction or strategic partnerships.

Material risks include very low liquidity typical of OTCQB stocks, potential equity dilution from future financings, execution risk for unproven initiatives and regulatory or compliance challenges that could materially affect prospects.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
1.35
Dividend Yield
-
Revenue TTM
6.29M
Revenue Per Share
0.41
Gross Profit TTM
3.85M
Debt / Equity
-
ROE
-7.67%
Net Debt
1.98M
ROCE
-3.61%
Diluted EPS TTM
-

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -0.88M -0.84M -2.47M -0.98M -1.99M
Net income -0.88M -0.84M -2.47M -0.98M -1.99M
Selling general administrative 3.37M 2.09M 3.87M 2.28M 2.58M
Gross profit 2.42M 1.91M 1.62M 1.37M 0.70M
Reconciled depreciation 0.15M -0.00M 0.00M 0.00M 0.01M
Ebit - - - - -1.84M
Ebitda - - - -0.91M -1.93M
Operating income -0.94M -0.18M -2.24M -0.91M -1.89M
Interest expense - - - - 0.05M
Net interest income -0.21M -0.19M -0.18M -0.06M -0.05M
Total revenue 4.51M 3.11M 2.49M 2.25M 1.47M
Total operating expenses 5.46M 3.30M 4.73M 3.16M 3.35M
Cost of revenue 2.09M 1.20M 0.86M 0.88M 0.77M
Total other income expense net 0.27M -0.47M -0.05M -0.01M -0.05M
Net income from continuing ops -0.88M -0.84M -2.47M -0.98M -1.99M
Net income applicable to common shares - - - -0.98M -1.99M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 27.82M 2.38M 2.64M 2.78M 3.03M
Intangible assets 0.53M 0.52M 0.52M 0.52M 0.52M
Other current assets 0.00M 0.01M 0.07M -0.00M -
Total liab 3.80M 1.97M 1.68M 0.90M 0.56M
Total stockholder equity 24.03M 0.41M 0.95M 1.88M 2.47M
Other current liab -0.00M 0.63M 0.15M 0.10M 0.09M
Common stock - - - - 0.34M
Capital stock 0.37M 0.35M 0.35M 0.35M 0.34M
Retained earnings -20.12M -19.24M -18.40M -15.93M -14.94M
Good will 21.12M 0.19M 0.19M 0.19M 0.19M
Other assets - - - - -0.00M
Cash 0.15M 0.11M 0.02M 0.07M 0.22M
Total current liabilities 1.69M 1.34M 1.68M 0.90M 0.56M
Net debt 1.98M 0.82M 1.03M 0.53M 0.12M
Short long term debt 0.71M 0.93M 1.05M 0.59M 0.34M
Other stockholder equity - - - 0.00M -
Property plant equipment - - - - 0.00M
Total current assets 1.33M 1.66M 1.90M 1.99M 2.31M
Net tangible assets - - - - 1.76M
Net receivables 0.19M 0.01M 0.03M 0.11M 0.13M
Long term debt 1.41M 0.00M - - -
Inventory 0.84M 1.36M 1.63M 1.82M 1.96M
Accounts payable 0.11M 0.05M 0.12M 0.09M 0.04M
Non currrent assets other -0.00M - -0.00M -0.00M -0.00M
Non current assets total 26.50M 0.72M 0.74M 0.79M 0.72M
Capital lease obligations 0.52M 0.01M 0.07M - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - 0.00M 0.00M -0.01M -0.10M
Change to liabilities - - - 0.00M -0.03M
Total cashflows from investing activities - - - -0.01M -0.10M
Net borrowings -0.19M -0.18M 0.39M - 0.17M
Total cash from financing activities -0.19M -0.19M 0.37M 0.19M 1.16M
Change to operating activities - - - - 0.07M
Net income -0.88M -0.84M -2.47M -0.98M -1.99M
Change in cash 0.03M 0.09M -0.05M -0.16M 0.16M
Begin period cash flow 0.11M 0.02M 0.07M 0.22M 0.06M
End period cash flow 0.15M 0.11M 0.02M 0.07M 0.22M
Total cash from operating activities 0.17M 0.28M -0.42M -0.33M -0.90M
Issuance of capital stock - - - - 1.00M
Depreciation 0.15M -0.00M 0.00M 0.00M 0.01M
Change to inventory 0.55M 0.27M 0.19M 0.14M 0.46M
Change to account receivables -0.14M 0.02M 0.08M 0.03M -0.12M
Sale purchase of stock 0.00M -0.01M -0.09M -0.01M -
Other cashflows from financing activities - - - -0.06M -0.06M
Change to netincome - - - 0.41M 0.69M
Capital expenditures 0.02M 0.00M 0.00M 0.01M 0.01M
Change in working capital 0.43M 0.31M 0.36M 0.23M 0.39M
Stock based compensation - - - 0.00M 0.00M
Other non cash items 0.42M 0.04M 0.00M -0.00M -
Free cash flow 0.15M 0.28M -0.42M -0.34M -1.00M

Peer Comparison*

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
HYEX
Grey Cloak Tech Inc
-
-%
1.35 - - 2.11 0.59 3.52 110.69
MKKGY
Merck KGaA ADR
0.45
1.38%
33.07 21.25 14.93 3.10 2.14 3.60 12.98
MKGAF
MERCK Kommanditgesellschaft auf Aktien
2.27
1.38%
167.12 24.86 15.11 3.13 1.98 3.08 18.89
TAK
Takeda Pharmaceutical Co Ltd ADR
0.31
1.47%
21.43 - 10.96 0.01 1.20 2.94 23.11
TKPHF
Takeda Pharmaceutical Co. Ltd.
-
-%
43.15 - 10.66 0.01 1.16 2.94 23.11

Profile*

Grey Cloak Tech Inc

Healthy Extracts Inc., through its subsidiaries, engages in acquiring, developing, patenting, marketing, and distributing plant-based nutraceuticals in the United States. It operates through Corporate and Health Supplements segments. The company's proprietary and patented products target categories within the nutraceuticals market, such as heart, brain, and immune health. It also provides heart and immune health products, including bergamot-based products in tablet and capsule form; and plant-based health technology neuro-products that enhance brain health comprising memory, cognition, focus, and neuro-energy. The company was formerly known as Grey Cloak Tech Inc. and changed its name to Healthy Extracts Inc. in October 2020. Healthy Extracts Inc. was incorporated in 2014 and is headquartered in Henderson, Nevada.

7375 Commercial Way, Henderson, NV, United States, 89011

720 463 1004

22

Name Title Year Born
Mr. Kevin Pitts CEO, Pres, Treasurer & Director 1960
Mr. Robert Madden CFO & Sec. 1972
Mr. J. Scott Landers Exec. VP of Sales & Marketing NA
Mr. Donald Swanson CEO & Chairman 1959
Mr. Kevin Pitts President, COO, Treasurer & Director 1960
Mr. Robert Madden CFO & Secretary 1972
Mr. J. Scott Landers Executive Vice President of Sales & Marketing NA
Mr. Aaron Hefter Chief Brand Officer 1981

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…